Stay updated on Pralsetinib vs Standard of Care in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Pralsetinib vs Standard of Care in NSCLC Clinical Trial page.

Latest updates to the Pralsetinib vs Standard of Care in NSCLC Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check17 days agoChange DetectedRevision: v3.5.4 replaces the previous Revision: v3.5.3 on this page, indicating a new version of the study record. This update reflects minor edits or clarifications to the document rather than changes to the study content itself.SummaryDifference0.0%

- Check23 days agoNo Change Detected
- Check38 days agoChange DetectedThe page’s displayed release/version number was updated from v3.5.2 to v3.5.3.SummaryDifference0.0%

- Check45 days agoChange DetectedPage revision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check52 days agoChange DetectedItaly location entry updated from Padua, Veneto, Italy, 35128 to Padova, Veneto, Italy, 35128.SummaryDifference0.0%

- Check66 days agoChange DetectedNaples, Campania, Italy, 80131 was added and Napoli, Campania, Italy, 80131 was removed from the location list. The update aligns site naming with English-language conventions and improves site identification for users.SummaryDifference0.0%

- Check74 days agoChange DetectedRevision: v3.5.0 added; Revision: v3.4.3 removed.SummaryDifference0.0%

Stay in the know with updates to Pralsetinib vs Standard of Care in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pralsetinib vs Standard of Care in NSCLC Clinical Trial page.